Jeri Ann Boose, Ph.D., director, Biopharmaceutical Services, will serve on the Viral Safety for Biologics Scientific Advisory Committee at IBC’s BioProcess International Conference in October in RI. Dr. Boose will present “Risk Mitigation Strategies for Non-Enveloped Viral Contaminants.”
Mark Glass, UK Business Development, has authored a Professional Scientific Staffing/Full Time Equivalent article titled “Sourcing the Right Solution” in the Irish Pharma Chem Buyers Guide.
Jeri Ann Boose, Ph.D., director, Biopharmaceutical Services, served as a Roundtable Participant with an “Overview of USP’s New General Information Chapter <1050.1> Design, Evaluation, and Characterization of Viral Clearance Procedures” at AAPS National Biotechnology Conference.
Robert J. Duff, Ph.D., manager, Biopharmaceutical Services, presented “Characterization of Antibody Drug Conjugates,” and Jeri Ann Boose, Ph.D., presented “Risk Mitigation Strategies for Non-Enveloped Viruses” at ISBiotech.
Jon S. Kauffman, Ph.D., director, Biopharmaceutical Services, contributed to “Meeting Challenges in Contract R&D” in BioProcess International, March 2012.